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Background: Bartonella bacilliformis is the etiological agent of
Carrion’s disease, a neglected illness with a febrile lethal stage and
a warty benign phase, being the human the only known reser-
voir. The diagnostic by microscopy in endemic areas is several
times erroneous. Furthermore, the culture of this bacterium is
time-consuming, being the diagnostic by PCR the easiest way to
performacorrect diagnostic. Theobjectiveof this studywas to eval-
uate the detection limit of three PCR schemes, designed to detect
B.bacilliformis, both in blood and ﬁlter papers to test their poten-
tial use for transferring samples from endemic areas to reference
centers. Moreover, the speciﬁcity was also observed as well as the
applicability of the technique with clinical samples from different
stages of the disease.
Methods&Materials: Fragments of 16SrRNA and ﬂa geneswere
ampliﬁed as well as the variable-intergenic region (its). The detec-
tion limit was determined by bacterial quantiﬁcation with ﬂow
cytometry and performing dilutions (106cfu/ml-10cfu/ml) both in
blood and ﬁlter papers. DNA was extracted and PCRs were per-
formed. Speciﬁcity was tested by processing other bacteraemia
microorganisms. Clinical samples, 12 from febrile patients, 13 from
warty and 71 from healthy asymptomatic individuals living in
endemic area(Mandinga-Cajamarca) were also processed.
Results: The 16SrRNA PCR scheme showed the lower detection
limit (5 cfu from blood and ﬁlter paper) being the PCR scheme cho-
sen to be tested in clinical samples. All febrile patients’ samples
were positive,whereas inwarty individuals only 3(23%) faint bands
were obtained. No ampliﬁcation was obtained in samples from
healthy people. Fainter bands were always obtained when PCRs
weremade of ﬁlter papers. All PCRswere speciﬁc for B.bacilliformis.
Conclusion: The 16SrRNA PCR seems to be the best technique
to detect feverish patients. However, the applicability to identify
asymptomatic carriers was undetermined. Filter paper may be an
alternative for easy transportation of samples but is need to con-
sider the decreasing sensitivity of the results. It is critical to develop
rapid, sensitive and speciﬁc technique capable of being applied in
endemic rural areas, to avoid misdiagnosis and facilitate the detec-
tion of asymptomatic carriers that will allow progress towards the
eradication of this disease.
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Use of 16S rRNA gene sequencing on direct
culture-negative clinical specimens for the
diagnosis of bacterial infections, including 2
case reports
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Background: Molecular techniques, such as 16S rRNA sequenc-
ing are useful for identiﬁcation of an unidentiﬁed bacterial isolate
as well as culture-negative clinical specimens. Where indicated,
our laboratory performs 16S rRNA sequencing on culture-negative
specimens. Two case studies are presented where the causative
pathogen was successfully identiﬁed by performing sequencing on
CSF and tissue which were culture-negative. As 16S is an expen-
sive and time-consuming investigation, specimen choice is critical.
Analysis of all specimens was undertaken and recommendations
are given.
Methods & Materials: Analysis of laboratory 16S data is pre-
sented.
Case study 1: A 44 year old female patient with AML pre-
sented with symptoms of ankle pain. The pain progressed to both
knee joints and the left wrist. After six weeks, discharge from the
left wrist was noted. Wash out of both knees and left wrist was
performed. Samples remained culture negative. 16S rRNA PCR on
tissue from both knees detected Ureaplasma urealyticum.
Case study 2: A 5 year old boy presented with otitis media,
seizures and meningitis. Microscopy on the ear swab showed
Gram-variable bacilli. The swab remained culture-negative.
Microscopy of the CSF showed an increased WBC and RBC count
and Gram-negative bacteria. No causative organism was identi-
ﬁed. 16S rRNA sequencing on the CSF identiﬁed the pathogen as
Fusobacterium necrophorum.
Results: 16S provided a useful diagnosis in both patients who
were then placed on appropriate antibiotic therapy. Since 2006,
>500 specimens have been referred to our laboratory for 16S rRNA
PCR. 90were clinical isolates sent for conﬁrmationofbacterial iden-
tiﬁcation. Thehighest yield came fromcardiac valve tissuewith48%
having a signiﬁcant pathogen identiﬁed. Tissues from other sites
had a yield of 23%. CSF, brain tissue or subdural abscess pus showed
the presence of a pathogen in 17.5% samples. Specimen quality and
quantity is critical to detect the presence of the causative organism.
Factors that affect the sensitivity of the assay are discussed.
Conclusion: 16S rRNA although an expensive and time labori-
ous technique does provide important information in cases where
routine culture techniques fail. The use of 16S rRNA should be
limited to clinically indicated caseswhere an appropriate specimen
is submitted.
http://dx.doi.org/10.1016/j.ijid.2014.03.1178
